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Abstract
Background: The soluble guanylyl cyclase (sGC) is a heterodimeric enzyme that, upon activation by nitric oxide,
stimulates the production of the second messenger cGMP. Each sGC subunit harbor four domains three of which
are used for heterodimerization: H-NOXA/H-NOBA domain, coiled-coil domain (CC), and catalytic guanylyl cyclase
domain. The CC domain has previously been postulated to be part of a larger CC family termed the signaling helix
(S-helix) family. Homodimers of sGC have also been observed but are not functionally active yet are likely transient
awaiting their intended heterodimeric partner.
Results: To investigate the structure of the CC S-helix region, we crystallized and determined the structure of the
CC domain of the sGCb1 subunit comprising residues 348-409. The crystal structure was refined to 2.15 Å
resolution.
Conclusions: The CC structure of sGCb1 revealed a tetrameric arrangement comprised of a dimer of CC dimers.
Each monomer is comprised of a long a-helix, a turn near residue P399, and a short second a-helix. The CC
structure also offers insights as to how sGC homodimers are not as stable as (functionally) active heterodimers via
a possible role for inter-helix salt-bridge formation. The structure also yielded insights into the residues involved in
dimerization. In addition, the CC region is also known to harbor a number of congenital and man-made mutations
in both membrane and soluble guanylyl cyclases and those function-affecting mutations have been mapped onto
the CC structure. This mutant analysis indicated an importance for not only certain dimerization residue positions,
but also an important role for other faces of the CC dimer which might perhaps interact with adjacent domains.
Our results also extend beyond guanylyl cyclases as the CC structure is, to our knowledge, the first S-helix structure
and serves as a model for all S-helix containing family members.
Background
Mammalian guanylyl cyclases are key signaling proteins
that produce the second messenger cGMP thereby regu-
lating a variety of different processes such as vasodila-
tion, diuresis, vision, and bone growth [1]. These
cyclases are either membrane bound or are found as
soluble forms. Members of the membrane guanylyl
cyclases (mGC) include the atrial natriuretic peptide
receptor (GC-A), heat-stable enterotoxin receptor (GC-
C), and retinal guanylyl cyclases (GC-E and -F) whereas
the soluble version is known as the soluble guanylyl
cyclase (sGC). cGMP produced by these guanylyl
cyclases activates downstream signaling proteins such as
cGMP-dependent kinases and cGMP-dependent ion
channels [2]. The cyclases are all activated by different
ligands that are in most cases recognized by the N-
terminal portion of the cyclases. Therefore, this N-term-
inal region is quite divergent amongst the different
cyclases [1]. In contrast, the C-terminal region of all the
cyclases have two domains found in all mammalian gua-
nylyl cyclases: the coiled-coil domain (CC) and the adja-
cent C-terminal catalytic guanylyl cyclase domain (GC)
(Figure 1). Considerable progress has been made on the
structural characterization of domains of the receptors,
or homologs thereof. These domains include the GC-A
receptor hormone-binding domain [3], homologous cat-
alytic guanylyl cyclase domains [4,5], and domains that
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oxide-and-oxygen binding domains (H-NOX or also
termed H-NOB) [6-9], and the H-NOXA/H-NOBA/PAS
domain [6,10]. One of the guanylyl cyclase domains that
has yet to be structurally characterized is the CC
domain and that is the focus of this study.
The mammalian sGC is a heterodimer with an a and
b subunits. Each subunit has two isoforms, a1 a2 b1
b2, yet the sGCa1b1 is the most abundant whereas the
sGCa2b1 is more predominant in brain tissue [11]. The
precise role for b2 subunit is not fully understood and it
could have a dominant negative regulatory role [12].
The subunit arrangement for sGCb1 includes the above
mentioned C-terminal CC and GC domains as well as
an N-terminal NO-sensing H-NOX/H-NOB and adja-
cent H-NOXA/H-NOBA/PAS domains. sGCa1 is 30%
sequence identical to sGCb1 and has a similar subunit
organization except that its N-terminal domain does not
contain a heme (Figure 1).
Besides heterodimerization, homodimers of sGC
homodimers have also been observed for b1[13], b2
[14], and the less stable a1 homodimer [15]. sGC homo-
dimers are not active [13], except for the Manduca sex-
ta’s b3 subunit [16] and the sGC b2 subunit although
the latter’s needs non-physiological manganese indicat-
ing that it might not be active and/or dimerized under
physiological conditions [14]. The homo- and heterodi-
meric forms of sGC are thought to be in a physiological
equilibrium [13] with heterodimerization being preferred
whereas homodimeric b1b1[ 1 7 ]a n da1a1 are found to
be unstable in vivo [18]. Understanding the underlying
reason for the instability of homodimeric sGC is impor-
tant as its subunit expression levels are known to
change [19-21] which could lead to uneven subunit
levels resulting in unstable sGC homodimers thereby
further affecting subunit levels. Dimerization within sGC
is mediated by at least three inter-domain interactions
involving the GC, H-NOXA/H-NOBA, and CC subdo-
mains. The latter two dimerization interactions were
found to be the most pronounced and include b1r e s i -
dues 204-244 (in H-NOXA domain) and residues 379-
408 (in CC domain)[22]; the corresponding regions in
sGCa1 are also critical for sGC activity [23]. Recent stu-
dies have narrowed down these dimerization regions via
deletion studies [24](Figure 1B) and even structurally
characterized an H-NOXA dimer [10] leaving the CC
region as the only region to be structurally explored.
The sequence of the CC region of guanylyl cyclases
are relatively conserved and are postulated to be part of
a larger class called the signaling helix (S-helix) [25].
This recent in silico study identifies this novel signaling
module in between diverse N-terminal sensory domains
and various C-terminal catalytic domains ranging from
histidine kinases, PP2C phosphatases, NtrC-like AAA+
ATPases, diguanylate cyclases to guanylyl cyclases.
Although members in this S-helix family share limited
but detectable sequence identity among each other,
their secondary structures are predicted to be entirely
helical. To our knowledge, no S-helix structure has yet
been determined so the elucidation of sGC CC S-helix
domain would not only contribute to the understanding
of guanylyl cyclase hetero- vs homodimerization, activa-
tion, domains cross-talk but also provides a structural
prototype for the entire S-helix family. We present here
the 2.15 Å crystal structure of the CC region of the
sGCb1.
Results
sGCb1 CC construct form oligomers in solution
The N- and C-terminal boundaries of the Rattus norve-
gicus sGC 348-409 CC domain were chosen such that it
starts after the PAS-like/H-NOXA domain and ends
before the cyclase domain (based on sequence and sec-
ondary structure analysis). This sGC CC monomer has a
theoretical pI of 5.62 and a calculated molecular weight
of 7712.86Da. We performed analytic gel filtration of
the CC construct prior to crystallization experiments to
estimate the oligomerization state of this construct (Fig-
ure 2). The majority of the CC protein eluted as a 38.5
kD protein and minor portion as a 19.5 kD protein.
Taking into account the non-globular nature of a
coiled-coil protein, which makes the protein appear with
a larger molecular weight, we assume that the majority
of the protein is tetrameric with a minor dimeric species
present. Similar results were obtained with native polya-
crylamide gel electrophoresis analysis (Figure 2). Efforts
regarding the corresponding CC domain in sGCa1t o
arrive at a heterodimeric CC complex were not success-
ful due to inability of the CC of sGCa1 to be expressed.
The sGCb1 CC monomers form an anti-parallel four-helix
bundle in crystal
We determined the crystal structure of the Rattus norvegi-
cus sGC CC domain (residues A348-K409) to 2.15 Å reso-
lution using SeMet single-anomalous-dispersion (SAD)-
phasing (Table 1). Crystals were initially obtained of the
wt sequence but the SAD phasing required the introduc-
tion of an additional Met residue via the I371 M mutation.
There are 8 CC molecules in the asymmetric unit and
each monomer contains a long amphipathic a helix aA
with 13 helical turns followed by a turn and a short helix
aB (Figure 3). The turn is initiated by a conserved proline
residue, P399 (Figure 1B, 3A, and 4). Four sGC CC mono-
mers come close together to form an apparent four-helix
bundle in an anti-parallel arrangement with two of such
tetramers in the asymmetric unit (Figure 3). The overall
dimensions of each tetramer is about 85 × 37 × 25 Å
3.
The rsGC CC domain is quite charged as 1/3 of its resi-
dues are either acidic or basic (12 D/E and 9 K/R). The
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Page 2 of 13Figure 1 Guanylyl cyclase domain structure and structure-based sequence alignment. A, domain organization of CC containing sGC and
mGCs (crystallized part in purple dotted line). B, Structure-based sequence alignment of CC and adjacent regions in rat sGCb1, sGCa1, sGCa2,
Manduca sexta sGCa1 and sGCb1, rat sGCb2, rat GC-A, and human GC-B, GC-E, GC-F, and GC-C. Also included are Npun02000820 of Nostoc
punctiforme PCC73102, labeled NpHNOXA, and the guanylyl cyclase of Chlamydomonas reinhardtii, labeled CrGC (in grey) to indicate the
proximity of the CC flanking H-NOXA and GC domains, respectively, as their structures have been determined [5,10] (residues included in the
structures are grey underlined with grey secondary structure elements). The sequence of the crystallized sGCb1 CC is bold with red secondary
structure elements. Completely conserved residues in the sGCs are highlighted green with possible conservation extending into mGCs. Mostly
conserved hydrophobic residues are in yellow; mostly conserved basic residues are in blue. sGCb1 residues 379-408 found to be important for
dimerization [22] are black underlined. sGCb1 residues 344-363, 381-400, and sGCa1 440-459 are important for sGC dimerization (red box); sGCb1
401-420 and sGCa1 460-479 are important for activity but not dimerization (blue box) [24]. The a-d designation based on the CC crystal
structure A:B dimer is generated using SOCKET [27] and slightly extended at the (frayed) ends. CC mutations [23,28,40-43] are shown in a black
box. Secondary structure predictions http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=/NPSA/npsa_seccons.html of all 7 top sequences
suggested a small helix present between the H-NOXA/PAS and aA helix (black dotted lines).
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Page 3 of 13eight monomers are conformationally similar to each
other, with root-mean-square deviation (r.m.s.d.) for Ca
atoms ranging between 0.27 Å and 1.50 Å based on pair-
wise structural comparisons (Figure 4A). Some of the
(four) N-terminal residues, introduced as cloning artifacts
(GSHM-) were ordered for each monomer. The two tetra-
mers in the asymmetric unit are similar as a superposition
of the two CC ‘tetramers’ results in a RMSD of 1.04 Å for
252 Ca atoms. The I371 M mutation that was generated
for SeMet phasing is not involved in the dimer or tetramer
interface. Note that the site of the I371 M mutation was
chosen carefully as to not to interfere with the predicted
a-d pattern of CC dimerization. The I at position 371 is
also not fully conserved in sGCb1a n dc a na l s ob eaV
(such as Manduca sexta,s e eF i g u r e1 ) ,o rM( i nd r o s o -
phila) suggesting that its mutation to M can be accommo-
dated and will likely not cause a negative effect on
dimerization and/or coiled-coil interactions.
Inter-monomer analysis of sGCb1 tetramer: dimer of
dimers
The interactions between the CC monomers within a
tetramer were analyzed using the PISA protein-interface
webserver [26]. The analysis revealed that the interface
buried between certain sets of monomer-monomers is
larger compared to others. The AB, CD, EF, and GH
interfaces are all larger compared to the AD, BC, EH,
and FH interfaces (Figure 3C). These differences were
even more pronounced for PISA’s calculated ΔGa n d
ΔG-P-value (Figure 3C) regarding these dimer interfaces
(P-values significantly below 0.5 indicate that a relative
higher percentage of the buried surface is hydrophobic
indicative of a biologically-relevant interface). Further-
more, if the short aB helix is removed from the calcula-
tions, since it is not part of the long coiled-coil helix,
the differences are even larger (ΔaB CC values in Figure
3C). The AB and CD interface are packed tighter as
well and therefore also have no waters present whereas
the AD and BC interfaces do have water molecules pre-
sent (Figure 3D). The tighter packing is evidenced as
the Ca-Ca distances between Ca’s in A and nearest Ca
in the B helix compared to the A and D helices are gen-
erally larger for the A-D pair (Figure 3E): the average
Ca-Ca distances for A:B helices (ignoring distances > 10
Å) is 7.3 Å and for the A:D helices is 8.3 Å.
Figure 2 Oligomerization state analysis of sGC CC domain. Size exclusion gel filtration chromatography of the CC sGCb1 using a Superdex
75 column resulted in an oligomeric 38.5 kD species (thick arrow) and a minor 19.5 kD species (thin arrow). The column was calibrated using a
mixture of different Mw standards (interrupted line). Inset, Native polyacrylamide gel electrophoresis analysis of CC sGCb1 (lane 1) and a mixture
of 3 Mw standards (lane M) revealing a major and minor species with similar Mw as obtained by size-exclusion chromatography (thick and thin
arrow, respectively).
Ma et al. BMC Structural Biology 2010, 10:2
http://www.biomedcentral.com/1472-6807/10/2
Page 4 of 13Figure 3 Structure of CC of sGCb1 and dimer analysis. A, Omit | Fo|- |F c| electron density of the C-terminal end of the aB helix of molecule
B, contoured at 2.5 s. B, schematic diagram of asymmetric unit contents of CC of sGCb1 revealing 2 CC tetramers. Shown are CC molecule A
(red) with the long aA and short aB helix labeled, as well as molecules B (blue), C (yellow), D magenta, E (light red), F (light blue), G (light
yellow), and H (light magenta). C, dimer interface calculations using PISA [26], D, different dimer interfaces and the presence or absence of water
molecules (red crosses) between monomers. E, graph depicting Ca-Ca distance for aA residues from molecule A to either the nearest residue in
molecule B (diamonds) or to molecule D (grey squares) that are shorter than 10 Å
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Page 5 of 13Figure 4 Structures of the monomer and dimer organization of CC sGCb1. A, superposition of the 8 CC monomers. B, three different views
of the AB dimer. Depicted also are the a-d residues at the dimer interface. Schematic diagram of anti-parallel CC dimer including a-g residue
assignment is included for reference to illustrate a-d appearance at the interface. C, sites of function-affecting mutations present in the CC region
of sGCs or mGCs are mapped onto the CC dimer sGCb1 structure. The second dimer, as part of the tetramer, is also depicted in a Ca trace with
a transparent solid surface.
Ma et al. BMC Structural Biology 2010, 10:2
http://www.biomedcentral.com/1472-6807/10/2
Page 6 of 13These different analyses indicate that the tetrameric
CC organization observed is likely comprised of a dimer
(Figure 4) of dimers and that the non-physiological tet-
ramer formation can perhaps be attributed to either the
a b s e n c eo ft h es G C a 1C Co rp e r h a p st h ep r e s e n c eo f
the N-terminal GSHM cloning residues of which the
non-native methionine (M347) is located at the tetramer
interface (Figure 4C). This dimer of dimers interpreta-
tion is in agreement with the CC dimer being also
observed as a minor dimeric species in solution (Figure
2). Since the expected CC oligomerization state of
guanylyl cyclases is dimeric, we narrow down our subse-
quent analysis to mainly the CC dimer.
Dimer analysis of sGCb1C C
The CC monomers A and B (and the equivalent CD, EF,
and GH) form an anti-parallel CC dimer (Figure 4B).
The side-chain directions of a-helices follow a heptad
(a-g) repeat in that residue i and i+7 face the same
direction. The CC dimer interface is formed predomi-
nantly via the a-d pattern residues and the a-d assign-
ment, as obtained from SOCKET [27], is indicated in
Figure 1B. A large number of the a-d residues are
hydrophobic which is the characteristic feature for CC
domains. Our observed a-d pattern was also predicted
by homology modeling of a S-helix [25] whereas the CC
of GC-E was modeled to have a different a-d pattern
[28]. Note that the observed a-d pattern for sGCb1 can
also be predicted from the sequence alone using
PCOILS [29] which predicted the same a-d assignment
for residues Y363-K389 with probability of higher than
0.75. However, the Marcoil prediction server [30]
yielded a different a-d assignments. These possible
ambivalences in a-d assignments could be used by the
CC domain for signaling perhaps via rotation of helices
as is also postulated to occur in the HAMP domain [31].
The CC of sGC harbors known regions found to be
critical for dimerization. These include the broadly
defined sGCa1 367-462 [15] and sGCb1 379-408 [22]
stretches (Figure 1B). A recent deletion study narrowed
these regions down to sGCb1 344-363 and 381-400 as
well as sGCa1 440-459 which were all found to be
important for dimerization [24]. sGCb1 401-420 and
sGCa1 460-479 were found to be important for activity
but not for dimerization [24](Figure 1B). The results
from this deletion study are in agreement with our CC
dimer structure since the latter two regions (which
includes aB helix) are not found at the dimer interface
whereas the other ones are at the dimer interface since
they are part of the long aA helix.
The CC domain is found in both mGCs and sGC and
other S-helix containing proteins [25]. The sequence
alignment shows considerable sequence conservation, in
particular in the C-terminal half of the S-helix (Figure
1B). The helix distance plot (Figure 3E) shows the dis-
t a n c eb e t w e e nt h ea Ah e l i c e si nt h em i d d l eo ft h eC C
A:B dimer is closer compared to the distances near the
ends of the helices.
CC orientation
The observation that the CC dimeric arrangement is
anti-parallel is somewhat unexpected since other groups
had suggested a parallel arrangement for guanylyl
cyclase CC domains after having carried out molecular
modeling studies of a parallel CC dimer [25,28]. Our
homo-oligomer CC sGCb1 structure is representative of
a physiologically present homodimeric sGCb1b1w h i c h ,
Table 1 X-ray data collection, phasing and refinement
statistics
Data collection Se-Peak
Wavelength (Å) 0.97926
Space group C2
Cell dimension a = 152.039 Å
b = 65.814 Å
c = 98.626 Å
b = 129.948°
Resolution (Å) 50.0-2.15 (2.23-2.15)
Total observations 298063
Unique observations 78615
I/SigI 10.9 (2.1)
Redundancy 3.8 (3.8)
Completeness 99.2 (99.5)
Rsym
a (%) 8.2 (34.6)
SAD phasing
Resolution 50.0-2.2
No. of Se sites
b 14
FOMSOLVE
c 0.3
FOMRESOLVE
d 0.64
Refinement
Resolution (Å) 50.0-2.15
No. of protein atoms 4152
No. of waters 460
Rwork (%) 21.3
Rfree(%) 26.1
RMSD bond length (Å) 0.010
RMSD bond angles (°) 1.21
Ramachandran plot
Most favoured (%) 98.3
Additionally allowed (%) 1.5
Generously allowed (%) 0.2
Disallowed (%) 0.0
Values in parentheses represent the highest resolution shell
aRsym(I)=ΣhklΣi|Ii(hkl)-〈I(hkl)〉|/ΣhklΣiIi(hkl) where the summations are over i
observations of each reflections and all hkl. 〈I(hkl)〉 is the average intensity of
the i observations. Rwork =| F(obs)-F(calc)|/F(obs)
bNumber of selenium sites located by SOLVE
cFigure of merit calculated from SOLVE
dFigure of merit calculated from RESOLVE
eRfree is calculated for 5% of randomly selected reflections not used in the
refinement
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Page 7 of 13in the full length sGC, was found to be not stable. Our
structure does not represent the active sGCa1b1 since it
was missing its heterodimeric sGCa1 CC partner in the
crystallization experiment. We therefore explored
whether a parallel arrangement was also a possibility in
t h ep r e s e n c eo fs G C a 1C C .C C ’s either parallel or anti-
parallel orientation possibilities were investigated by
considering the possibilities of salt-bridge formation,
residue preference at a-d positions, and inter-domain
constraints.
-Potential salt-bridge formation
Whereas the a-d positions of a CC are favored to have
leucine-like residues to promote CC formation, the resi-
dues at the e and g positions can be found to make
inter-helix salt-bridges [32,33]: parallel CCs are observed
to form g-e’ salt-bridges whereas anti-parallel CCs can
form g-g’ and e-e’ salt-bridges. To analyze the possible
formations of such salt-bridges in both orientations for
both homodimeric sGCb1 and heterodimer sGCa1b1,
we generated models of the different possible CCs. To
generate an anti-parallel heterodimeric sGCa1b1a AC C
dimer, we used COOT [34] to mutate the residues of
one of the monomers to the sGCa1 sequence using the
alignment in Figure 1B. To obtain a parallel sGCb1
homodimer, we used the coordinates of the parallel
RhoKinase CC dimer [35](PDBid 1UIX) as template for
superimposing the sGCb1 CC using the a-d residue
assignment as guide. This generated homodimeric CC
model was used to make a heterodimeric parallel CC
model via changing the residues of one of the mono-
mers into the sGCa1 sequence using COOT. These 3
models of aA helix CC dimers were not refined using
minimization methods as they merely serve the purpose
of visualizing the possibilities of salt-bridge formation of
residues at the e and g positions. The following salt-
bridges are possible for CC homo-/heterodimers in
either a parallel or anti-parallel CC orientation:
-Anti-parallel heterodimer g-g’ or e-e’ salt-bridges: 1
(sGCa1 K448-sGCb1 E361)
-Anti-parallel homodimer g-g’ or e-e’ salt-bridges: 4
(sGCb1 E368-sGCb1 R375; sGCb1 E361-sGCb1 K389
and their two symmetry related ones)
-Parallel heterodimer g-e’ salt-bridges: 2 (sGCa1 K432:
sGCb1 E368, sGCa1 K425-sGCb1 E361).
-Parallel homodimer g-e’ salt-bridges: 0
This analysis suggests that only in the parallel CC
orientation is there a possible electrostatic attraction
benefit of a1b1 heterodimer formation compared to
b1b1 homodimer formation (number of salt-bridges can
increase from 0 to 2).
-L, V, I, N residue preferences
In addition to electrostatic attraction, the presence of
leucine, valine, isoleucine, and asparagine residues at
either a or d positions can yield clues regarding the
parallel or anti-parallel nature of CCs. Based on the ana-
lyses of previous dimeric CC structures, the Ld:La ratio
for parallel was found to be 3.5 but was 1.2 for anti-par-
allel CCs [36]. In addition, the same study found that
for the branched residues valine and isoleucine, the ratio
of (V+I)a:(V+I)d was 14.2 for parallel and only 1.8 for
anti-parallel. This ratio is also in agreement with that
the isoleucine residue was found to be difficult to be
accommodated at the d position for parallel CCs [37].
Finally, parallel CCs were found to have a 4-fold prefer-
ence for asparagine residue at the a position compared
to anti-parallel CCs [27]. To investigate whether these
a/d position preferences can aid in suggesting whether
CCs from sGCs and mGCs are parallel or anti-parallel,
we analyzed their a-d appearance using the sequence
alignment in Figure 1B as well as an expanded sGC
alignment including 15 sGC-only sequences (results
listed in brackets): Ld:La = 32:23 (45:42), (V+I)a:(V+I)d =
17:0 (22:0), and Na:Nd = 1:0 (3:0). These results indicate
that the a:d appearance of three of the four analyzed
residues (V, I, and N) suggest that the CC orientation
could be parallel (the L is less conclusive).
-Inter-domain distance constraints
Finally, an additional clue regarding parallel vs anti-par-
allel CCs can come from the fact that these different
orientations would have different distances between
their termini which have to still somehow connect to
their adjacent domains via intervening residues. We
therefore constructed partial composite models of the
H-NOXA/CC/GC domains with in one case a parallel
and the other an anti-parallel CC orientation (Figure 5).
The H-NOXA dimer and the GC dimer are taken from
recently determined crystal structures [5,10] and part of
their sequence is also included in the sequence align-
ment to show their sequence proximity to the CC (Fig-
ure 1B). The sequence identity between the Ns HNOXA
and the sGCb1 H-NOXA domain is 35% and the iden-
tity between the GC domains of sGCb1a n dt h em a m -
malian Chlamydomonas reinhardtii GC structure is
42%. In the anti-parallel arrangement, the distance
between the two N-termini of the CC dimer is ~85 Å
whereas the distance between the two C-termini of the
H-NOXA dimer is only ~20 Å (Figure 5). These differ-
ences indicate that each connection would need to
stretch about (85-20)/2 = 32.5 Å. This distance is rather
large but can perhaps be reached via the 20 intervening
residues between these domains (Figure 1B) as each Ca-
Ca distance of adjacent residues is ~4 Å. Regarding the
other inter-domain connections, the distance between
the anti-parallel CC C-termini is 60 Å whereas the dis-
tance between the N-termini of the GC dimer is only 30
Å (Figure 5). This indicates that each linker would need
to stretch about (60-30)/2 = 15 Å which is too large for
having only 2 intervening residues between CC and GC
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Page 8 of 13(Figure 1B). These calculations are of course dependent
on that either the H-NOXA or GC dimer does not
change globally (or locally) during activation but both of
those have either been speculated to possibly change
(for H-NOXA [10]) or observed to change (for a homo-
logous adenylyl cyclase dimer [38]). With the parallel
CC arrangement, these inter-domain N- and C-termini
distances are shorter and therefore more compatible
(Figure 5). It should however be noted that the termini
in proteins structures are often flexible thereby possibly
changing these distance-based extrapolations. Based on
the above arguments indicating that the sGCa1bb1 CC
is likely parallel, we were able to expand the partial (CC
parallel) composite model of the heterodimeric sGC by
adding in the H-NOX coordinates [9] and positioning
this domain such its C-termini and the N-termini of H-
NOXA are in close proximity and that H-NOX can also
interact with the GC domain (not shown); this latter
requirement satisfied the direct H-NOX/GC interaction
that has previously been observed [39].
Finally, the fact that the C-terminal half of the CC
domain is more conserved across the different cyclases
(sGCb1 residue 376-408; Figure 1B), and likely of differ-
ent length as also noted earlier [6,25], is also indicative
of a parallel helix arrangement as the conserved regions
will interact with each other which would not occur in
an anti-parallel CC arrangement.
Mapping of guanylyl cyclase CC mutations
The CC domain present in mGCs and sGCs has been
the site of a number of genetic mutations and has also
been targeted by mutagenesis to probe structure-func-
tion. Our crystal structure of CC domain allows us to
now map the sites of these mutations on the CC struc-
ture to possibly gain additional structure-function
knowledge.
First, the CC domain of sGCa1 of the medeka fish
Oryzias latipes has been targeted for mutagenesis for
structure-function studies [23]. The a1 mutations (with
the rat a1 sequence number in parenthesis) L434K
(L424) and L445K (L435) each caused a slight decrease
in dimerization and no decrease of NO stimulation yet
increased basal activity by ~3-fold. The a1 L463K (L453)
mutation caused loss of basal and NO stimulated activ-
ity and slight decrease in dimerization. Combining these
mutations in a triple mutant decreased the dimerization
to ~30% of wt; adding L452K (L442) mutant to form a
quadruple mutant dropped the dimerization to only 10%
of wt. Secondly, the retinal guanylyl cyclase GC-E can
harbor several blindness causing mutations in the CC
domain (R838 [28,28], P858 [40], the double mutation
Figure 5 organization of heterodimeric sGC based on CC orientation. Possible H-NOXA/CC/GC organization based on an anti-parallel CC
dimer (left) and based on a parallel CC dimer (right). The H-NOXA/H-NOBA (yellow), CC (red), and GC (blue) domains are depicted. Distances of
C-terminus:C-terminus and N-terminus:N-terminus within either dimeric H-NOXA/H-NOBA, CC, or GC are shown using grey arrows.
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Page 9 of 13Q847L/K848Q [41], and I816S [42]). In addition, either
of the GC-E double mutants L824S/Y827S and L831S/
L834S affected receptor function [28]. Thirdly, the GC-
A receptor also has one mutation (L845R) that is
located within the CC and found to cause loss of activity
but not loss of dimerization [43]. Note that this latter
mutation is equivalent to the O. latipes sGCa1 L463K
(L453) mutant (Figure 1B) suggesting that this residue is
of considerable importance in both mGCs and sGCs.
This residue is equivalent to sGCb1 L394 which is mak-
ing a 4 Å van der Waals interaction with L355. The
above mentioned function-affecting CC mutations are
listed in the sequence alignment (Figure 1B) and their
equivalent residues in sGCb1 are mapped onto their
structure (Figure 4). The mutations are roughly evenly
distributed along the full length of the CC aA helix as
there appears to be no clear concentration of mutations.
Furthermore, not all mutations correspond to residues
at the a-d positions, indicating a critical functional role
for CC regions within and outside the dimerization
interface.
Discussion
We have determined the structure of the CC domain of
sGCb1 which revealed a long aA helix, a short turn, fol-
l o w e db yas h o r ta Bh e l i x .T h eoligomeric state at first
inspection seems to reveal a tetrameric anti-parallel
arrangement yet our detailed analysis suggests that the
dimer-of-dimers tetrameric arrangement is non-physio-
logical and likely due to the hydrophobic end regions of
the CC normally preferring to interact with other sGC
protein regions that are missing in our crystallized con-
struct. These hydrophobic CC end regions ended up
therefore packing against another CC dimer to form this
non-physiological tetramer. Within the CC dimer struc-
ture, we argue that the observed anti-parallel nature of
the CC arrangement in the sGCb1b1 homodimer is
likely different from that in full length heterodimeric
sGC since its sGCa1 CC partner is missing. In addition
to having analyzed the possibilities of salt-bridge forma-
tion, residue preference at a-d positions, and inter-
domain constraints regarding parallel vs anti-parallel CC
formation for the S-helix, additional analysis also sug-
gests a parallel arrangement as will be discussed next.
The S-helix is found in other non-guanylyl cyclase
domain containing proteins and its proximity to other
domains could also yield insights into the orientation
arrangement since the distance of the termini is very
different for the two different orientations. For example,
the S-helix is also found in front of a diguanylate cyclase
domain ([25] and this dimeric protein has an N-termi-
nus-N-terminus distance of ~25 Å (PDBid 1W25[44],
which is more compatible with a parallel CC dimer. In
addition, the S-helix is often found N-terminal to a
DHp domain or N-terminal and C-terminal of the
HAMP domain [25]. Both the DHp and HAMP domain
are 4-helix bundle dimerized domains with their N-ter-
minus-N-terminus or C-terminus-C-terminus distances
being as short as 8, 14, or 38 Å (PDBids 2ASW and
3D36). Anantharaman et al. had therefore previously
suggested that the S-helix could perhaps merge/extend
from the termini of these HAMP and DNp domains
[25] which would only be possible in a parallel CC
arrangement. In summary, the CC/S-helix region found
in cyclases and other proteins is very likely in a parallel
arrangement yet the observed anti-parallel CC in the
sGCb1b1 is likely physiological relevant as will be dis-
cussed next.
The sGCb1 homodimer CC structure revealed an anti-
parallel arrangement of the monomers and might shed
some light into how sGC has evolved to favor heterodi-
merization over homodimerization (with homodimers
not even being very stable). sGC has evolved this char-
acteristic despite that many of the individual subunits
are known to homo-dimerize by themselves. The dimer-
ization Kd’s for the catalytic domain a1a1 and b1b1
homodimers are 10-20 μMa n d~ 6μM, respectively
[ 3 9 ] .F u r t h e r m o r e ,s G C b1 H-NOXA domain homo-
dimerization Kd is less than 60 μM [10] and the b1C C
dimerization is likely also in the μM range. Therefore,
having at least three domains each with about a ~10
-5M
homodimerization Kd constant within one protein
would normally yield, due to avidity, an overall homodi-
merization binding constant in the nM if not pM range.
Such an extrapolated strong affinity would normally ren-
der the homodimers quite stable and it is therefore sur-
prising that sGC homodimers are found to be unstable
[13,17,18]. A possible unifying explanation could per-
haps be the non-compatibility of the homo-dimeric CC
orientation with respect to the position of the flanking
domains: only a parallel CC would align its flanking
domains correctly whereas an anti-parallel CC dimer, as
observed in our sGCb1b1 CC structure, might likely not
(Figure 5). Such a homo-dimer disfavoring mechanism
could be important since only the sGC heterodimer is
catalytically functional making it vital for the sGC subu-
nits not to form stable yet unproductive homodimeric
complexes. We realize that such a mechanism might be
unique to sGC, being heterodimeric, as many other S-
helix family members are homodimeric. Perhaps a con-
tributing factor to the uniqueness of part of sGC’s
homo-dimer disfavoring mechanism could be the possi-
bility of unique 1-residue register slippage changes in
the middle of the S-helix [25](Figure 1).
Conformational changes upon activation
C C sa r ek n o w nt ob eq u i t es e n s i t i v ea ss m a l lc h a n g e st o
CCs have been known to affect oligomerization and helix
orientation (reviewed in [37]). The CC region in guanylyl
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been postulated to be important for regulation/signaling.
This possibly regulatory role for the CC was observed in
mutagenesis and modeling studies for GC-E indicating
that this region was not optimized for dimerization but
more for regulation as R838 mutations increased activity
and might structurally extend/lengthen the CC region
[28]. A bioinformatics study also suggested a regulatory/
signaling role for the CC region and has termed this
region in cyclases a signaling or S-helix [25]. Both of these
studies have indicated the S-helix to be parallel CC and
modeled it as such. Some possible CC conformational
changes could involve a loop-to-helix transition, as
observed in influenza virus hemagglutinin HA2 [45], a
shifting/flipping along the interface of the a-d knobs, as
modeled for GCN4 [46], or rotation of the helices as evi-
denced in the HAMP structure [31]. In addition, a helix
re-orientation from anti-parallel to parallel or vice versa
can also not be ruled out.
Despite the above emphasis of the CC in guanylyl
cyclases possibly being a signaling module, it is likely
that not all signaling of the upstream domains in mGCs
and sGCs goes solely through the CC domain to reach
the catalytic GC domain. This is evident from that the
H-NOX domain can directly interact and inhibit the GC
domain in sGC [39].
In addition to possible conformational changes invol-
ving just the long aA helix, activation conformational
changes could also involve interactions of other sGC
regions interacting with the end regions of the CC since
t h e r ea r ean u m b e ro fr e s i d ues with conserved hydro-
phobicity (i.e. L352, V353, L354, L394, and L398). These
end regions could perhaps interact with either CC’s own
aB helix, as in our structure since aB folds back on aA,
and/or the small helix predicted to be between the H-
NOXA and CC domain (see Figure 1B). The CC aA
helix could thus use the hydrophobic regions towards
its ends that in our sGCb1 structure form also part of
the dimer of dimer interactions. It is noteworthy that
the CC ends harbor two conserved residues that are
found to be critical for mGC and sGC activation (corre-
sponding to sGCb1 L394 and P399 as described above
in the “Mapping of Guanylyl Cyclase CC Mutations”
sections, Figure 1B and 4C) suggesting an important
role for this region in receptor activation and/or interac-
tions with the other subdomains of sGC.
Future structural studies are needed to determine the
structure of sGC’s heterodimeric CC alone and in the
intact sGC and what the activation conformational
changes are within this region.
Conclusions
We have determined the crystal structure of the sGCb1
CC domain to 2.15 Å resolution. This CC structure
revealed a long a-helix, a turn near residue P399, fol-
lowed by a short second a-helix. CC domains are known
for their oligomerization behavior and we therefore ana-
lyzed the inter-molecule interactions within the asym-
metric unit which indicated a dimeric arrangement of
the CC sGCb1 subunits. Additional sequence analysis
and modeling of homo- and heterodimeric CCs allowed
us to speculate that the hetero-dimerization preference
over homo-dimerization of sGC subunits could be, in
part, due to inter-helix salt-bridge formation. The CC
region has been shown to be a critical region for guany-
lyl cyclase functioning and is the site for a number of
congenital and man-made mutations in both membrane
and soluble guanylyl cyclases. The CC sGCb1 structure
allowed mapping of those function-affecting mutations
which pointed to an important role for some of the
dimerization region but also for residues not involved in
the dimer interface. This latter observation suggests that
other CC surfaces are also important with perhaps hav-
ing a role in interacting with the other flanking subdo-
mains of sGC. Our results also extend beyond guanylyl
cyclases as the CC structure is, to our knowledge, the
first S-helix structure and serves as a model for all S-
helix containing family members.
Methods
Cloning and mutagenesis of rsGCb1 CC domain
The coding sequence (residues 348-409) for the CC
region from rsGCb1w a ss u b c l o n e di n t ot h ep E T 1 5 b
vector between Nde I and BamH I restriction sites using
the following primer set: Forward primer: 5’-gga att cca
tat ggc tac acg aga cct ggt cct ttt-3’, backward primer:
5’-cgc gga tcc tca ctt gtg tct cag ctc att ggc aac-3’.T h e
I371 M mutant was generated by site directed mutagen-
esis method, to facilitate structure determination by
SeMet phasing (forward primer: 5’-ca caa gag ctg gaa
atG ctc aca gac agg ctg c-3’ and backward primer: 5’-g
cag cct gtc tgt gag Cat ttc cag ctc ttg tg-3’). The result-
ing pET15b_rsGCb1_348-409I371 M plasmid encodes
the following polypeptides in the T7 expression region:
mgsshhhhhhssglvpr/gshmATRDLVLLGEQFREEYKLT-
QELEMLTDRLQLTLRALEDEKKKTDTLLYSVLPPSVA-
NELRHK (The residues that belong to rsGCb1a r e
shown as uppercase letters. The single mutation was
indicated in bold font. Other residues in lower case are
introduced as cloning artifact.)
Expression and purification of rsGCb1 CC domain
The pET15b_rsGCb1_348-409I371 M vectors were
transformed into E. coli BL21 (DE3) pLysS cells (Invitro-
gen). The bacteria were grown in 8L M9 minimal media
containing 50 μg/mL ampicillin and 37 μg/mL chloram-
phenicol at 37°C until a cell density of 1.2-1.4 OD600
was reached. The protein expression was induced with
300 μMi s o p r o p y l - b-D-thiogalactopyranoside (IPTG)
Ma et al. BMC Structural Biology 2010, 10:2
http://www.biomedcentral.com/1472-6807/10/2
Page 11 of 13supplemented with essential amino acids and seleno-
methionine for 8 hours at 37°C. The cells were har-
vested by centrifugation at 6000 rpm, followed by
freezing at -80°C. The pellet was thawed on ice, resus-
pended in buffer A containing 20 mM Tris-HCl, 100
mM NaCl, 2 mM b-mercaptoethanol and lysed by soni-
cation. The crude lysate was clarified by centrifugation
at 16,000 rpm for 15 minutes, incubated with 3 mL Ni-
NTA (Qiagen) for 4 hours and washed with buffer A
plus 15 mM imidazole extensively. The protein was
eluted using 50 mM buffer A plus 350 mM imidazole
and dialyzed against 4L buffer A overnight. Thrombin
(Sigma) digestion was carried out afterwards at 20°C for
8 hours and monitored by SDS-PAGE. The untagged
protein product was loaded onto a Hitrap Q-sepharose
(Amersham-Pharmacia Biotech) column and eluted with
NaCl gradient. Fractions containing protein of interest
were pooled together, concentrated and frozen in ali-
quots at -80°C. Prior to crystallization trials, a gel filtra-
tion polishing step using Superdex75 (Amersham-
Pharmacia Biotech) was applied and the final protein
buffer is 10 mM Tris-HCl, 100 mM NaCl, 2 mM b-
mercaptoethanol.
rsGCb1 CC domain crystallization
X-ray diffraction-quality crystals of the CC construct were
obtained at 20°C with the sitting-drop method by mixing
2 μlo ft h ep r o t e i ns o l u t i o nw i t h1μl of the precipitant
solution. Drops were equilibrated with a well containing
300 μl of 0.1 M Bis-Tris pH 7.0, and 0.7 M Ammonium
Sulfate. Crystals of average dimensions of 300*20*20 μm
3
were grown in the above condition. For data collection at,
the crystals were stepwise transferred into mother liquor
reservoir solution with 5%, 10%, and 15% glycerol prior to
freezing the crystal for data collection.
rsGCb1 CC domain structure determination and
refinement
AS i n g l eA n o m a l o u sD i s p e r sion (SAD) dataset for the
rsGCb1_348-409-I371 M crystal was collected at NSLS
X29 beamline at Se peak wavelengths to 2.15 Å resolu-
tion and processed with HKL2000 [47]. The crystal
belongs to space group C2, with cell dimensions a =
152.039 Å, b = 65.814 Å, c = 98.626 Å, b = 129.948°
and eight molecules in the asymmetric unit. The pro-
gram SOLVE/RESOLVE [48] was used to locate the
selenium sites, calculate the experimental phases, and
build an initial partial model. Refinement was carried
out using REFMAC [49] alternated with rounds of man-
ual model rebuilding and water picking using COOT
[34]. The stereochemistry was checked using PRO-
CHECK [50](Table 1). Figures are generated using
Pymol http://pymol.sourceforge.net/. Coordinates and
structure factors for the sGCb1 CC domain have been
deposited with the PDB (PDB identifier 3HLS).
Abbreviations
sGC: soluble guanylyl cyclase; H-NOX: heme-nitric-oxide-and-oxygen binding
domain (or H-NOB); H-NOXA: heme-nitric-oxide-and-oxygen binding
associate domain (or H-NOBA); H-NOB: heme nitric oxide binding domain;
H-NOBA: heme nitric oxide binding domain associated domain; CC: coiled-
coil; GC: guanylyl cyclase; ECD: extra-cellular domain; TM: transmembrane
helix; KHD: kinase-homology domain.
Acknowledgements
We thank beam line support personnel at NSLS. This work is supported by
grants from the NIH to FvdA (R01 HL075329) and AB (R01 GM067640) and
the AHA (SDG 0335159N) to FvdA.
Author details
1Department of Biochemistry/RT500, Case Western Reserve University, 10900
Euclid Ave. Cleveland, OH 44106, USA.
2Department of Pharmacology and
Physiology, UMDNJ - New Jersey Medical School Medical Sciences Building,
I655/I664 185 S. Orange Avenue, Newark, NJ 07103, USA.
Authors’ contributions
XM designed and carried out the experiments and wrote the initial draft of
the manuscript. AB helped plan the experiments and aided in the
manuscript revisions. FVDA designed experiments, analyzed the data and
helped write the manuscript. All authors read and approved the final
manuscript.
Received: 27 August 2009
Accepted: 27 January 2010 Published: 27 January 2010
References
1. Padayatti PS, Pattanaik P, Ma X, Akker van den F: Structural insights into
the regulation and activation mechanism of mammalian guanylyl
cyclases. Pharmacol Ther 2004, 104:83-99.
2. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S,
Chepenik KP, Waldman SA: Guanylyl cyclases and signaling by cyclic
GMP. Pharmacol Rev 2000, 52:375-414.
3. Akker van den F, Zhang X, Miyagi M, Huo X, Misono KS, Yee VC: Structure
of the dimerized hormone-binding domain of a guanylyl-cyclase-
coupled receptor. Nature 2000, 406:101-104.
4. Rauch A, Leipelt M, Russwurm M, Steegborn C: Crystal structure of the
guanylyl cyclase Cya2. Proc Natl Acad Sci USA 2008, 105:15720-15725.
5. Winger JA, Derbyshire ER, Lamers MH, Marletta MA, Kuriyan J: The crystal
structure of the catalytic domain of a eukaryotic guanylate cyclase. BMC
Struct Biol 2008, 8:42.
6. Iyer LM, Anantharaman V, Aravind L: Ancient conserved domains shared
by animal soluble guanylyl cyclases and bacterial signaling proteins.
BMC Genomics 2003, 4:5.
7. Pellicena P, Karow DS, Boon EM, Marletta MA, Kuriyan J: Crystal structure of
an oxygen-binding heme domain related to soluble guanylate cyclases.
Proc Natl Acad Sci USA 2004, 101:12854-12859.
8. Nioche P, Berka V, Vipond J, Minton N, Tsai AL, Raman CS: Femtomolar
sensitivity of a NO sensor from Clostridium botulinum. Science 2004,
306:1550-1553.
9. Ma X, Sayed N, Beuve A, Akker van den F: NO and CO differentially
activate soluble guanylyl cyclase via a heme pivot-bend mechanism.
EMBO J 2007, 26:578-588.
10. Ma X, Sayed N, Baskaran P, Beuve A, van den AF: PAS-mediated
dimerization of soluble guanylyl cyclase revealed by signal transduction
histidine kinase domain crystal structure. J Biol Chem 2008,
283:1167-1178.
11. Mullershausen F, Koesling D, Friebe A: NO-sensitive guanylyl cyclase and
NO-induced feedback inhibition in cGMP signaling. Front Biosci 2005,
10:1269-1278.
12. Vazquez-Padron RI, Pham SM, Mateu D, Khan S, Aitouche A: An internal
ribosome entry site mediates the initiation of soluble guanylyl cyclase
beta2 mRNA translation. FEBS J 2008, 275:3598-3607.
13. Zabel U, Hausler C, Weeger M, Schmidt HH: Homodimerization of soluble
guanylyl cyclase subunits. Dimerization analysis using a glutathione s-
transferase affinity tag. J Biol Chem 1999, 274:18149-18152.
Ma et al. BMC Structural Biology 2010, 10:2
http://www.biomedcentral.com/1472-6807/10/2
Page 12 of 1314. Koglin M, Vehse K, Budaeus L, Scholz H, Behrends S: Nitric oxide activates
the beta 2 subunit of soluble guanylyl cyclase in the absence of a
second subunit. J Biol Chem 2001, 276:30737-30743.
15. Wagner C, Russwurm M, Jager R, Friebe A, Koesling D: Dimerization of
nitric oxide-sensitive guanylyl cyclase requires the alpha 1 N terminus. J
Biol Chem 2005, 280:17687-17693.
16. Morton DB, Anderson EJ: MsGC-beta3 forms active homodimers and
inactive heterodimers with NO-sensitive soluble guanylyl cyclase
subunits. J Exp Biol 2003, 206:937-947.
17. Mergia E, Friebe A, Dangel O, Russwurm M, Koesling D: Spare guanylyl
cyclase NO receptors ensure high NO sensitivity in the vascular system.
J Clin Invest 2006, 116:1731-1737.
18. Friebe A, Mergia E, Dangel O, Lange A, Koesling D: Fatal gastrointestinal
obstruction and hypertension in mice lacking nitric oxide-sensitive
guanylyl cyclase. Proc Natl Acad Sci USA 2007, 104:7699-7704.
19. Gerassimou C, Kotanidou A, Zhou Z, Simoes DC, Roussos C,
Papapetropoulos A: Regulation of the expression of soluble guanylyl
cyclase by reactive oxygen species. Br J Pharmacol 2007, 150:1084-1091.
20. de Frutos S, Nitta CH, Caldwell E, Friedman J, Gonzalez Bosc LV: Regulation
of Soluble Guanylyl Cyclase-{alpha}1 Expression in Chronic Hypoxia-
induced Pulmonary Hypertension:Role of NFATc3 and HuR. Am J Physiol
Lung Cell Mol Physiol 2009, 297:L475-L486.
21. Cabilla JP, Ronchetti SA, Nudler SI, Miler EA, Quinteros FA, Duvilanski BH:
Nitric oxide sensitive-guanylyl cyclase subunit expression changes
during estrous cycle in anterior pituitary glands. Am J Physiol Endocrinol
Metab 2009, 296:E731-E737.
22. Zhou Z, Gross S, Roussos C, Meurer S, Muller-Esterl W, Papapetropoulos A:
Structural and functional characterization of the dimerization region of
soluble guanylyl cyclase. J Biol Chem 2004, 279:24935-24943.
23. Shiga T, Suzuki N: Amphipathic alpha-helix mediates the
heterodimerization of soluble guanylyl cyclase. Zoolog Sci 2005,
22:735-742.
24. Rothkegel C, Schmidt PM, Atkins DJ, Hoffmann LS, Schmidt HH, Schroder H,
Stasch JP: Dimerization Region of Soluble Guanylate Cyclase
Characterized by Bimolecular Fluorescence Complementation in vivo.
Mol Pharmacol 2007, 72:1181-1190.
25. Anantharaman V, Balaji S, Aravind L: The signaling helix: a common
functional theme in diverse signaling proteins. Biol Direct 2006, 1:25.
26. Krissinel E, Henrick K: Detection of Protein Assemblies in Crystals.
Computational Life Sciences Springer-Verlag Berlin HeidelbergBerthold MR
2005, 3695:163-174.
27. Walshaw J, Woolfson DN: Socket: a program for identifying and analysing
coiled-coil motifs within protein structures. J Mol Biol 2001,
307:1427-1450.
28. Ramamurthy V, Tucker C, Wilkie SE, Daggett V, Hunt DM, Hurley JB:
Interactions within the coiled-coil domain of RetGC-1 guanylyl cyclase
are optimized for regulation rather than for high affinity. J Biol Chem
2001, 276:26218-26229.
29. Gruber M, Soding J, Lupas AN: REPPER–repeats and their periodicities in
fibrous proteins. Nucleic Acids Res 2005, 33:W239-W243.
30. Delorenzi M, Speed T: An HMM model for coiled-coil domains and a
comparison with PSSM-based predictions. Bioinformatics 2002, 18:617-625.
31. Hulko M, Berndt F, Gruber M, Linder JU, Truffault V, Schultz A, Martin J,
Schultz JE, Lupas AN, Coles M: The HAMP domain structure implies helix
rotation in transmembrane signaling. Cell 2006, 126:929-940.
32. Monera OD, Kay CM, Hodges RS: Electrostatic interactions control the
parallel and antiparallel orientation of alpha-helical chains in two-
stranded alpha-helical coiled-coils. Biochemistry 1994, 33:3862-3871.
33. Taylor CM, Keating AE: Orientation and oligomerization specificity of the
Bcr coiled-coil oligomerization domain. Biochemistry 2005, 44:16246-16256.
34. Emsley P, Cowtan K: Coot: model-building tools for molecular graphics.
Acta Crystallogr D Biol Crystallogr 2004, 60:2126-2132.
35. Shimizu T, Ihara K, Maesaki R, Amano M, Kaibuchi K, Hakoshima T: Parallel
coiled-coil association of the RhoA-binding domain in Rho-kinase. J Biol
Chem 2003, 278:46046-46051.
36. Walshaw J, Woolfson DN: Socket: a program for identifying and analysing
coiled-coil motifs within protein structures. J Mol Biol 2001,
307:1427-1450.
37. Apgar JR, Gutwin KN, Keating AE: Predicting helix orientation for coiled-
coil dimers. Proteins 2008, 72:1048-1065.
38. Tews I, Findeisen F, Sinning I, Schultz A, Schultz JE, Linder JU: The structure
of a pH-sensing mycobacterial adenylyl cyclase holoenzyme. Science
2005, 308:1020-1023.
39. Winger JA, Marletta MA: Expression and characterization of the catalytic
domains of soluble guanylate cyclase: interaction with the heme
domain. Biochemistry 2005, 44:4083-4090.
40. Tucker CL, Ramamurthy V, Pina AL, Loyer M, Dharmaraj S, Li Y,
Maumenee IH, Hurley JB, Koenekoop RK: Functional analyses of mutant
recessive GUCY2D alleles identified in Leber congenital amaurosis
patients: protein domain comparisons and dominant negative effects.
Mol Vis 2004, 10:297-303.
41. Yoshida S, Yamaji Y, Yoshida A, Kuwahara R, Yamamoto K, Kubata T,
Ishibashi T: Novel triple missense mutations of GUCY2D gene in
Japanese family with cone-rod dystrophy: possible use of genotyping
microarray. Mol Vis 2006, 12:1558-1564.
42. Rezaie T, Karimi-Nejad MH, Meshkat MR, Sohbati S, Karimi-Nejad R,
Najmabadi H, Sarfarazi M: Genetic screening of leber congenital
amaurosis in a large consanguineous Iranian family. Ophthalmic Genet
2007, 28:224-228.
43. Miao ZH, Song DL, Douglas JG, Chang CH: Mutational inactivation of the
catalytic domain of guanylate cyclase-A receptor. Hypertension 1995,
25:694-698.
44. Chan C, Paul R, Samoray D, Amiot NC, Giese B, Jenal U, Schirmer T:
Structural basis of activity and allosteric control of diguanylate cyclase.
Proc Natl Acad Sci USA 2004, 101:17084-17089.
45. Huang Q, Korte T, Rachakonda PS, Knapp EW, Herrmann A: Energetics of
the loop-to-helix transition leading to the coiled-coil structure of
influenza virus hemagglutinin HA2 subunits. Proteins 2009, 74:291-303.
46. Laughton CA, Luisi BF, Pratap JV, Calladine CR: A potential molecular
switch in an alpha-helical coiled coil. Proteins 2008, 70:25-30.
47. Otwinowski Z, Minor W: Processing of X-ray diffraction data collected in
oscillation mode. Methods Enzymol 1997, 276:307-326.
48. Terwilliger TC, Berendzen J: Automated MAD and MIR structure solution.
Acta Crystallogr D Biol Crystallogr 1999, 55:849-861.
49. Murshudov GN, Vagin AA, Dodson EJ: Refinement of macromolecular
structures by the maximum-likelihood method. Acta Crystallogr D Biol
Crystallogr 1997, 53:240-255.
50. Laskowski RA, MacArthur MW, Moss DS, Thornton JM: PROCHECK - a
program to check the stereochemical quality of protein structures. J
Appl Cryst 2001, 26:283-291.
doi:10.1186/1472-6807-10-2
Cite this article as: Ma et al.: Crystal structure of the signaling helix
coiled-coil domain of the b1 subunit of the soluble guanylyl cyclase.
BMC Structural Biology 2010 10:2.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Ma et al. BMC Structural Biology 2010, 10:2
http://www.biomedcentral.com/1472-6807/10/2
Page 13 of 13